Package 43066-035-05

Brand: verapamil hydrochloride

Generic: verapamil hydrochloride
NDC Package

Package Facts

Identity

Package NDC 43066-035-05
Digits Only 4306603505
Product NDC 43066-035
Product ID 43066-035_65fb1861-d681-4c27-9428-52df91e72e16
Description

5 VIAL, SINGLE-DOSE in 1 CARTON (43066-035-05) / 4 mL in 1 VIAL, SINGLE-DOSE (43066-035-01)

Marketing

Marketing Status
Marketed Since 2020-03-25
Brand verapamil hydrochloride
Generic verapamil hydrochloride
Sample Package No

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "65fb1861-d681-4c27-9428-52df91e72e16", "openfda": {"upc": ["0343066035013", "0343066031015"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["03c5daf8-5399-4d89-a747-9a9d7667b6e4"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (43066-035-05)  / 4 mL in 1 VIAL, SINGLE-DOSE (43066-035-01)", "package_ndc": "43066-035-05", "marketing_start_date": "20200325"}], "brand_name": "Verapamil Hydrochloride", "product_id": "43066-035_65fb1861-d681-4c27-9428-52df91e72e16", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "43066-035", "generic_name": "verapamil Hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA213232", "marketing_category": "ANDA", "marketing_start_date": "20200325", "listing_expiration_date": "20261231"}